Brief: Radiopharm Theranostics Says HY Loss A$24.8 Million Versus Loss A$12.6 Million
29/02/2024 06:10
Feb 29 (Reuters) - Radiopharm Theranostics Ltd RAD.AX :
* HY LOSS A$24.8 MILLION VERSUS LOSS A$12.6 MILLION
Source text for Eikon: ID:nASX7k149L
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%